Skip to main content
Erschienen in: Journal of Natural Medicines 1/2010

01.01.2010 | Natural Resource Letter

Antiviral activities of diarylheptanoids against influenza virus in vitro

verfasst von: Rie Sawamura, Yi Sun, Ken Yasukawa, Tomomi Shimizu, Wataru Watanabe, Masahiko Kurokawa

Erschienen in: Journal of Natural Medicines | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

The anti-influenza A/PR/8/34 (H1N1) virus activities of ten diarylheptanoids isolated from Alpinia officinarum were examined using the MTT method. The 50% inhibitory concentration of each diarylheptanoid examined was clearly lower than its 50% cytotoxic concentration determined by the MTT assay and/or maximum non-cytotoxic concentration (MNCC) determined by the morphological change of cells. In particular, the influenza virus was more susceptible to 7-(4″-hydroxy-3″-methoxyphenyl)-1-phenyl-4E-hepten-3-one (3) and (5S)-5-hydroxy-7-(4″-hydroxyphenyl)-1-phenyl-3-heptanone (8) than the other diarylheptanoids. Thus, all diarylheptanoids exhibited potential antiviral activity against influenza virus in vitro.
Literatur
1.
Zurück zum Zitat Hayden FG (1996) Amantadine and rimantadine––clinical aspects. In: Richman DD (ed) Antiviral drug resistance. Wiley, London, pp 59–77 Hayden FG (1996) Amantadine and rimantadine––clinical aspects. In: Richman DD (ed) Antiviral drug resistance. Wiley, London, pp 59–77
2.
Zurück zum Zitat Ison MG, Hayden FG (2001) Therapeutic options for the management of influenza. Curr Opin Pharmacol 1:482–490CrossRefPubMed Ison MG, Hayden FG (2001) Therapeutic options for the management of influenza. Curr Opin Pharmacol 1:482–490CrossRefPubMed
3.
Zurück zum Zitat Pitts SR (2002) Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness. Ann Emerg Med 39:552–554CrossRefPubMed Pitts SR (2002) Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness. Ann Emerg Med 39:552–554CrossRefPubMed
4.
Zurück zum Zitat Englund JA, Champlin RE, Wyde PR, Kantarjian H, Atmar RL, Tarrand J, Yousuf H, Regnery H, Klimov AI, Cox NJ, Whimbey E (1998) Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 26:1418–1424CrossRefPubMed Englund JA, Champlin RE, Wyde PR, Kantarjian H, Atmar RL, Tarrand J, Yousuf H, Regnery H, Klimov AI, Cox NJ, Whimbey E (1998) Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 26:1418–1424CrossRefPubMed
5.
Zurück zum Zitat McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F, Zambon M (2003) Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 47:2264–2272CrossRefPubMed McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F, Zambon M (2003) Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 47:2264–2272CrossRefPubMed
6.
Zurück zum Zitat Wetherall NT, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin JL, Zambon M, Hayden FG (2003) Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 41:742–750CrossRefPubMed Wetherall NT, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin JL, Zambon M, Hayden FG (2003) Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 41:742–750CrossRefPubMed
7.
Zurück zum Zitat Yasukawa K, Sun Y, Kitanaka S, Tomizawa N, Miura M, Motohashi S (2008) Inhibitory effect of the rhizomes of Alpinia officinarum on TPA-induced inflammation and tumor promotion in two-stage carcinogenesis in mouse skin. Nat Med 62:374–378CrossRef Yasukawa K, Sun Y, Kitanaka S, Tomizawa N, Miura M, Motohashi S (2008) Inhibitory effect of the rhizomes of Alpinia officinarum on TPA-induced inflammation and tumor promotion in two-stage carcinogenesis in mouse skin. Nat Med 62:374–378CrossRef
8.
Zurück zum Zitat Ly TN, Shimoyamada M, Kato K, Yamauchi R (2003) Isolation and characterization of some antioxidative compounds from the rhizomes of smaller galanga (Alpinia officinarum Hance). J Agric Food Chem 51:4924–4929CrossRefPubMed Ly TN, Shimoyamada M, Kato K, Yamauchi R (2003) Isolation and characterization of some antioxidative compounds from the rhizomes of smaller galanga (Alpinia officinarum Hance). J Agric Food Chem 51:4924–4929CrossRefPubMed
9.
Zurück zum Zitat Ly TN, Shimoyamada M, Kato K, Yamauchi R (2004) Antioxidative compounds isolated from the rhizomes of smaller galanga (Alpinia officinarum Hance). Biofactors 21:305–308CrossRefPubMed Ly TN, Shimoyamada M, Kato K, Yamauchi R (2004) Antioxidative compounds isolated from the rhizomes of smaller galanga (Alpinia officinarum Hance). Biofactors 21:305–308CrossRefPubMed
10.
Zurück zum Zitat Sun Y, Tabata K, Matsubara H, Kitanaka S, Suzuki T, Yasukawa K (2008) New cytotoxic diarylheptanoids from the rhizomes of Alpinia officinarum. Planta Med 74:427–431CrossRefPubMed Sun Y, Tabata K, Matsubara H, Kitanaka S, Suzuki T, Yasukawa K (2008) New cytotoxic diarylheptanoids from the rhizomes of Alpinia officinarum. Planta Med 74:427–431CrossRefPubMed
11.
Zurück zum Zitat Lee HJ, Kim JS, Ryu J-H (2006) Suppression of inducible nitric oxide synthase expression by diarylheptanoids from Alpinia officinarum. Planta Med 72:68–71CrossRefPubMed Lee HJ, Kim JS, Ryu J-H (2006) Suppression of inducible nitric oxide synthase expression by diarylheptanoids from Alpinia officinarum. Planta Med 72:68–71CrossRefPubMed
12.
Zurück zum Zitat Kiuchi F, Shibuya M, Sankawa U (1982) Inhibitors of prostaglandin biosynthesis from Alpinia officinarum. Chem Pharm Bull 30:2279–2282 Kiuchi F, Shibuya M, Sankawa U (1982) Inhibitors of prostaglandin biosynthesis from Alpinia officinarum. Chem Pharm Bull 30:2279–2282
13.
Zurück zum Zitat Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U (1992) Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 40:387–391PubMed Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U (1992) Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 40:387–391PubMed
14.
Zurück zum Zitat Sun Y, Matsubara H, Kitanaka S, Yasukawa K (2008) Diarylheptanoids from the rhizomes of Alpinia officinarum. Helv Chim Acta 91:118–123CrossRef Sun Y, Matsubara H, Kitanaka S, Yasukawa K (2008) Diarylheptanoids from the rhizomes of Alpinia officinarum. Helv Chim Acta 91:118–123CrossRef
15.
Zurück zum Zitat Shimizu T, Hino A, Tsutsumi A, Park YK, Watanabe W, Kurokawa M (2008) Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice. Antivir Chem Chemother 19:7–13PubMed Shimizu T, Hino A, Tsutsumi A, Park YK, Watanabe W, Kurokawa M (2008) Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice. Antivir Chem Chemother 19:7–13PubMed
16.
Zurück zum Zitat Watanabe W, Konno K, Ijichi K, Inoue H, Yokota T, Shigeta S (1994) MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents. J Virol Methods 48:257–265CrossRefPubMed Watanabe W, Konno K, Ijichi K, Inoue H, Yokota T, Shigeta S (1994) MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents. J Virol Methods 48:257–265CrossRefPubMed
17.
Zurück zum Zitat Furuta Y, Takahashi K, Fukuda Y, Kuno M, Kamiyama T, Kozaki K, Nomura N, Egawa H, Minami S, Watanabe Y, Narita H, Shiraki K (2002) In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother 46:977–981CrossRefPubMed Furuta Y, Takahashi K, Fukuda Y, Kuno M, Kamiyama T, Kozaki K, Nomura N, Egawa H, Minami S, Watanabe Y, Narita H, Shiraki K (2002) In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother 46:977–981CrossRefPubMed
18.
Zurück zum Zitat Shin D, Kinoshita K, Koyama K, Takahashi K (2002) Antiemetic principles of Alpinia officinarum. J Nat Prod 65:1315–1318CrossRefPubMed Shin D, Kinoshita K, Koyama K, Takahashi K (2002) Antiemetic principles of Alpinia officinarum. J Nat Prod 65:1315–1318CrossRefPubMed
19.
Zurück zum Zitat An N, Xu L-Z, Zou Z-M, Yang S-L (2006) Diarylheptanoids from Alpinia officinarum. J Asian Nat Prod Res 8:637–641CrossRefPubMed An N, Xu L-Z, Zou Z-M, Yang S-L (2006) Diarylheptanoids from Alpinia officinarum. J Asian Nat Prod Res 8:637–641CrossRefPubMed
Metadaten
Titel
Antiviral activities of diarylheptanoids against influenza virus in vitro
verfasst von
Rie Sawamura
Yi Sun
Ken Yasukawa
Tomomi Shimizu
Wataru Watanabe
Masahiko Kurokawa
Publikationsdatum
01.01.2010
Verlag
Springer Japan
Erschienen in
Journal of Natural Medicines / Ausgabe 1/2010
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-009-0372-2

Weitere Artikel der Ausgabe 1/2010

Journal of Natural Medicines 1/2010 Zur Ausgabe